Cantabria Labs aims for €800 million in revenue by 2030, powered by growth in Latin America and the US


The Spanish dermatology group is on track to grow by 14% in 2026, and has set its targets for 2030. Italian CEO and SVP business & ventures, Stefano Fatelli, unveils the group’s strategies and key markets.

The Spanish dermatology group is on track to grow by 14% in 2026, and has set its targets for 2030. Italian CEO and SVP business & ventures, Stefano Fatelli, unveils the group’s strategies and key markets.